PERGOLIDE IN LATE-STAGE PARKINSON DISEASE

被引：58

作者：

LANG, AE

QUINN, N

BRINCAT, S

MARSDEN, CD

PARKES, JD

机构：

[1] UNIV LONDON,INST PSYCHIAT,DEPT NEUROL,LONDON SE5 8AF,ENGLAND

[2] UNIV LONDON KINGS COLL HOSP,LONDON SE5 8RX,ENGLAND

来源：

关键词：

D O I：

10.1002/ana.410120305

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：243 / 247

页数：5

共 13 条

[1] BROMOCRIPTINE ASSOCIATED WITH A PERIPHERAL DOPAMINE BLOCKING-AGENT IN TREATMENT OF PARKINSONS-DISEASE
AGID, Y
BONNET, AM
POLLAK, P
SIGNORET, JL
LHERMITTE, F
[J]. LANCET, 1979, 1 (8116) : 570 - 572
[2] DUVOISIN RC, 1981, NEUROLOGY, V31, P133
[3] EFFECTS OF (8-BETA)-8-[(METHYLTHIO)METHYL]-6-PROPYLERGOLINE ON DOPAMINERGIC FUNCTION AND BRAIN DOPAMINE TURNOVER IN RATS
FULLER, RW
CLEMENS, JA
KORNFELD, EC
SNODDY, HD
SMALSTIG, EB
BACH, NJ
[J]. LIFE SCIENCES, 1979, 24 (04) : 375 - 382
[4] INTERACTION OF PERGOLIDE WITH CENTRAL DOPAMINERGIC RECEPTORS
GOLDSTEIN, M
LIEBERMAN, A
LEW, JY
ASANO, T
ROSENFELD, MR
MAKMAN, MH
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06): : 3725 - 3728
[5] Goldstein M, 1980, Adv Biochem Psychopharmacol, V23, P75
[6] LADURON PM, 1979, BIOCHEM PHARMACOL, V28, P2162
[7] PHARMACOLOGIC EFFECTS IN MAN OF A POTENT, LONG-ACTING DOPAMINE RECEPTOR AGONIST
LEMBERGER, L
CRABTREE, RE
[J]. SCIENCE, 1979, 205 (4411) : 1151 - 1153
[8] TREATMENT OF ADVANCED PARKINSON DISEASE WITH PERGOLIDE
LIEBERMAN, A
GOLDSTEIN, M
LEIBOWITZ, M
NEOPHYTIDES, A
KUPERSMITH, M
PACT, V
KLEINBERG, D
[J]. NEUROLOGY, 1981, 31 (06) : 675 - 682
[9] PARKES JD, 1970, LANCET, V1, P1130
[10] BROMOCRIPTINE TREATMENT IN PARKINSONS-DISEASE
PARKES, JD
MARSDEN, CD
DONALDSON, I
GALEADEBONO, A
WALTERS, J
KENNEDY, G
ASSELMAN, P
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1976, 39 (02) : 184 - 193